NCPA

Women Pharmacy Ownership on the RiseHow women are becoming more involved than ever in pharmacy.
DIR Fees: What NCPA Wants from Part DIn a letter to the CMS, DIR fees take precedence
New Report: PBMs Push Drug Costs
New Report: PBMs Push Drug CostsAre PBMs responsible for higher drug prices or is something else to blame?
Why This PBM Comparison Is a Bit of a WhopperAre pharmacies really comparable to fast-food outlets?
Keep prescription drug benefits in ACA, NCPA urgesNCPA sends letter to Senate on prescription issues in health-care reform.
Reader Response
5 Ways to Improve Medicare Part DNCPA’s recommendations for improving the “increasingly complicated Part D marketplace.”
Pharmacists Are Flying In to Washington to Talk and PersuadeDIR fees top pharmacy legislator meetings.
Surescripts Takes Aim at Improving e-Prescribing AccuracyNew monitoring system identifies problems with e-prescription systems.
Pharmacists to Descend on Washington
Pharmacists to Descend on WashingtonDIR fees and health-care reform will lead pharmacists’ legislative concerns.